Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroimaging in multiple sclerosis.

Robert Zivadinov1, Jennifer L Cox

  • 1Buffalo Neuroimaging Analysis Center, The Jacobs Neurological Institute, State University of New York at Buffalo, School of Medicine and Biomedical Sciences, Buffalo, New York 14203, USA.

International Review of Neurobiology
|May 29, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Healthcare Practice Post COVID-19 Impacts: Will 21st Century Pharmacists Become Global, Agile, Collaborative and Curated?

Pharmacy (Basel, Switzerland)·2025
Same author

Relationship between brain atrophy and disability in a multi-site multiple sclerosis registry.

BMJ neurology open·2025
Same author

A systematic literature review of the association between global brain atrophy and the Expanded Disability Status Scale score in people with multiple sclerosis.

Therapeutic advances in neurological disorders·2025
Same author

Exploring the natural age cutoff point for primary-progressive multiple sclerosis therapy.

Expert review of neurotherapeutics·2025
Same author

Neuroimaging phenotype characterization of early aggressive and late severe multiple sclerosis: a case-control study.

Brain communications·2025
Same author

Verona validation of the DAAE score, a tool for estimating risk of clinical disease progression in people with multiple sclerosis.

Multiple sclerosis and related disorders·2025

Conventional magnetic resonance imaging (MRI) for multiple sclerosis (MS) lacks sensitivity. Newer MRI techniques offer better detection of subtle brain changes and correlate more strongly with patient disability.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Conventional magnetic resonance imaging (MRI) is standard for multiple sclerosis (MS) diagnosis and monitoring.
  • Current MRI metrics like lesion volume and count lack sensitivity and specificity for MS pathology.
  • Conventional MRI fails to detect occult gray matter demyelination and correlate poorly with clinical disability.

Purpose of the Study:

  • To highlight the limitations of conventional MRI in assessing multiple sclerosis (MS) pathology.
  • To emphasize the need for advanced MRI techniques for comprehensive MS assessment.
  • To demonstrate the superior correlation of novel MRI metrics with neurological impairment.

Main Methods:

  • Review of conventional MRI metrics (lesion volume, gadolinium-enhancing, T2 lesions).

Related Experiment Videos

  • Discussion of advanced MRI techniques: T1-weighted hypointense lesions, atrophy measures, magnetization transfer imaging, magnetic resonance spectroscopy, and diffusion tensor imaging.
  • Comparison of conventional and nonconventional MRI metrics in relation to neuropathological findings and clinical disability.

    • Main Results:

    • Conventional MRI metrics inadequately capture the full spectrum of MS-related tissue damage, including gray matter pathology.
    • Advanced MRI techniques provide a more global assessment of inflammation and neurodegeneration.
    • Nonconventional MRI measures show a stronger correlation with neurological impairment and disability compared to conventional metrics.

    Conclusions:

    • Conventional MRI is insufficient for fully characterizing MS pathology and its impact on disability.
    • Novel MRI techniques are crucial for detecting occult lesions and providing a more accurate assessment of MS.
    • Advanced MRI metrics offer better correlation with clinical outcomes, aiding in prognosis and therapeutic evaluation.